Ji Cheng

1.7k total citations · 1 hit paper
33 papers, 1000 citations indexed

About

Ji Cheng is a scholar working on Oncology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Ji Cheng has authored 33 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Biomedical Engineering and 7 papers in Molecular Biology. Recurrent topics in Ji Cheng's work include Lymphoma Diagnosis and Treatment (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Advanced Sensor and Energy Harvesting Materials (4 papers). Ji Cheng is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Advanced Sensor and Energy Harvesting Materials (4 papers). Ji Cheng collaborates with scholars based in Canada, China and United States. Ji Cheng's co-authors include Xiao Yu Wu, Matthew J. Matasar, Muhıt Özcan, Grace Ku, Tae Min Kim, Andrew McMillan, Christopher R. Flowers, Laurie H. Sehn, Manali Kamdar and Mark Hertzberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Ji Cheng

28 papers receiving 986 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

2019 459 citations Laurie H. Sehn, Alex F. Herrera et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ji Cheng Canada	15	474	373	182	155	137	33	1000
Mihai Danciu Romania	14	370 0.8×	111 0.3×	232 1.3×	60 0.4×	121 0.9×	63	1.1k
Ling Lu China	22	503 1.1×	137 0.4×	823 4.5×	178 1.1×	85 0.6×	64	1.8k
Guanghui Li China	22	264 0.6×	133 0.4×	621 3.4×	115 0.7×	78 0.6×	88	1.4k
Shiyong Zhou China	16	259 0.5×	191 0.5×	248 1.4×	180 1.2×	89 0.6×	71	767
Ké Li China	22	357 0.8×	90 0.2×	785 4.3×	87 0.6×	56 0.4×	96	1.5k
Jiali Cheng China	20	460 1.0×	83 0.2×	532 2.9×	308 2.0×	52 0.4×	63	1.5k
Katharina Leithner Austria	25	270 0.6×	283 0.8×	887 4.9×	124 0.8×	126 0.9×	45	2.0k
Guangyu Yao China	20	359 0.8×	96 0.3×	638 3.5×	346 2.2×	106 0.8×	45	1.4k
Zhiwen Yao China	13	498 1.1×	39 0.1×	551 3.0×	339 2.2×	452 3.3×	32	1.9k
Jorrit De Waele Belgium	19	594 1.3×	80 0.2×	470 2.6×	163 1.1×	65 0.5×	36	1.4k

Countries citing papers authored by Ji Cheng

Since Specialization

Citations

This map shows the geographic impact of Ji Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Cheng more than expected).

Fields of papers citing papers by Ji Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Cheng. The network helps show where Ji Cheng may publish in the future.

Co-authorship network of co-authors of Ji Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ji Cheng. A scholar is included among the top collaborators of Ji Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji Cheng. Ji Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Nan, et al.. (2025). Construction and effectiveness of a pharmacist-involved diabetes management model between tertiary hospitals and community under the hierarchical medical system. Frontiers in Clinical Diabetes and Healthcare. 6. 1658713–1658713.

Zhou, Bing, et al.. (2025). Study on medication adherence in patients with gestational diabetes mellitus complicated by postpartum glucose metabolism disorders based on the risk perception attitude framework. Frontiers in Endocrinology. 16. 1501541–1501541.

Li, Huaying, et al.. (2024). Evaluating Preferences of Hospitalized Diabetes Patients for Hospital‐Wide Glycemic Control Programme: A Discrete Choice Experiment. Journal of Diabetes Research. 2024(1). 2552658–2552658.

Liu, Jia, et al.. (2023). Risk Factors for Granulocytopenia in Patients with Graves’ Disease Receiving Antithyroid Drugs. International Journal of Endocrinology. 2023. 1–5.

Liu, Jia, et al.. (2023). Identification of Risk Factors and Development of a Predictive Model for Postoperative Hypoglycemia among Diabetic Patients during the Perioperative Period. International Journal of Endocrinology. 2023. 1–8. 1 indexed citations

Yang, Na, Ji Cheng, Jiajia Ge, et al.. (2023). Metabolic alteration of circulating steroid hormones in women with gestational diabetes mellitus and the related risk factors. Frontiers in Endocrinology. 14. 1196935–1196935. 8 indexed citations

Li, Fengyang, Ji Cheng, Qing Shu, et al.. (2021). Mesencephalic astrocyte-derived neurotrophic factor restores blood–brain barrier integrity of aged mice after ischaemic stroke/reperfusion through anti-inflammation via TLR4/MyD88/NF-κB pathway. Figshare. 18 indexed citations

Sehn, Laurie H., Matthew J. Matasar, Christopher R. Flowers, et al.. (2019). Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study. Blood. 134(Supplement_1). 4081–4081. 14 indexed citations

Sehn, Laurie H., Alex F. Herrera, Matthew J. Matasar, et al.. (2018). Polatuzumab Vedotin (Pola) Plus Bendamustine (B) with Rituximab (R) or Obinutuzumab (G) in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Updated Results of a Phase (Ph) Ib/II Study. Blood. 132(Supplement 1). 1683–1683. 15 indexed citations

10.

Sehn, Laurie H., Manali Kamdar, Alex F. Herrera, et al.. (2018). Randomized phase 2 trial of polatuzumab vedotin (pola) with bendamustine and rituximab (BR) in relapsed/refractory (r/r) FL and DLBCL.. Journal of Clinical Oncology. 36(15_suppl). 7507–7507. 38 indexed citations

11.

Sehn, Laurie H., Alex F. Herrera, Matthew J. Matasar, et al.. (2017). Addition of Polatuzumab Vedotin to Bendamustine and Rituximab (BR) Improves Outcomes in Transplant-Ineligible Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Versus BR Alone: Results from a Randomized Phase 2 Study. Blood. 130. 2821–2821. 16 indexed citations

12.

Zhang, Ruixue, Tian Zhang, Ji Cheng, et al.. (2017). Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice. Journal of Visualized Experiments. 7 indexed citations

13.

Zhang, Ruixue, Ping Cai, Jason Li, et al.. (2016). Polymer–lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin–mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor. Nanomedicine Nanotechnology Biology and Medicine. 12(5). 1279–1290. 75 indexed citations

14.

Cheng, Ji, Lü Jin, Wenhuan Feng, et al.. (2016). Effects of Exenatide on Metabolie Changes, Sexual Hormones, Inflammatory Cytokines, Adipokines, and Weight Change in a DHEA-Treated Rat Model. Reproductive Sciences. 23(9). 1242–1249. 29 indexed citations

15.

Ping, Wu, Ji Cheng, Mingli Wang, Zou S, & Weihong Ge. (2013). Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine. Annales d Endocrinologie. 74(1). 56–58. 6 indexed citations

16.

Kim, Keekyoung, Ji Cheng, Qun Liu, Xiao Yu Wu, & Yu Sun. (2009). Investigation of mechanical properties of soft hydrogel microcapsules in relation to protein delivery using a MEMS force sensor. Journal of Biomedical Materials Research Part A. 92A(1). 103–113. 82 indexed citations

17.

Liu, Qun, Adam J. Shuhendler, Ji Cheng, et al.. (2009). Cytotoxicity and mechanism of action of a new ROS-generating microsphere formulation for circumventing multidrug resistance in breast cancer cells. Breast Cancer Research and Treatment. 121(2). 323–333. 17 indexed citations

18.

Kim, Keekyoung, Xinyu Liu, Yong Zhang, et al.. (2008). Elastic and viscoelastic characterization of microcapsules for drug delivery using a force-feedback MEMS microgripper. Biomedical Microdevices. 11(2). 421–427. 51 indexed citations

19.

Kim, Keekyoung, Xinyu Liu, Yong Zhang, et al.. (2008). Mechanical characterization of polymeric microcapsules using a force-feedback MEMS microgripper. PubMed. 2008. 1845–1848. 8 indexed citations

20.

Cheng, Ji, et al.. (1994). Antitumor agents. 144. New .gamma.-lactone ring-modified arylamino etoposide analogs as inhibitors of human DNA topoisomerase II. Journal of Medicinal Chemistry. 37(2). 287–292. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact